HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

AbstractBACKGROUND:
The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS development and to improve treatment results. The aim of this study was to analyze novel endothelium-biomarkers for PTS in patients with DVT out of the acute phase.
METHODS:
A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclusion and used to diagnose and classify the severity of PTS. Plasma inter-cellular adhesion molecule 1 (ICAM-1), P-selectin, fractalkine and vascular endothelial growth factor (VEGF) were quantified using cytometric bead array. Endothelial progenitor cells (EPCs) and circulating endothelial cells (CEC) level were quantified by flow cytometry.
RESULTS:
Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P  = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82); P  = 0.0021) compared to no PTS patients. Patients with PTS had significantly higher levels of fractalkine (387.60 pg/ml (222.30-597.90) vs. 98.00 pg/ml (82.30-193.02); P  = 0.044) than patients without PTS. Fracktalkine levels showed a strong linear correlation with Villalta score, r  = 0.86, P  < 0.0001. No differences were observed in P-selectin, ICAM-1 and VEGF between studied groups.
CONCLUSIONS:
The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the development of PTS. These results suggest a possible role of these mediators in the maintenance and worsening of PTS turning them into potential therapeutic targets.
AuthorsSabrina Ranero, Gonzalo Silveira, Natalia Trias, Andreina Brugnini, Daniela Lens, Cecilia Guillermo, Sofía Grille
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 34 Issue 3 Pg. 144-151 (Apr 01 2023) ISSN: 1473-5733 [Electronic] England
PMID37016998 (Publication Type: Journal Article)
CopyrightCopyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Chemical References
  • Chemokine CX3CL1
  • P-Selectin
  • Vascular Endothelial Growth Factor A
  • Intercellular Adhesion Molecule-1
  • Biomarkers
Topics
  • Humans
  • Postthrombotic Syndrome (diagnosis, etiology)
  • Venous Thrombosis (drug therapy)
  • Chemokine CX3CL1
  • P-Selectin
  • Vascular Endothelial Growth Factor A
  • Case-Control Studies
  • Intercellular Adhesion Molecule-1 (therapeutic use)
  • Endothelial Cells
  • Biomarkers
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: